BRCA1 and breast cancer: HMECs were screened for differences in viscoelastic phenotypes across six primary strains: three from average‐risk women (aged 33–40 years) without any known breast cancer‐causing germline mutations, and three from high‐risk women (aged 24–35 years) with BRCA1 germline mutations (Table S3, Supporting Information).